Birch Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Birch pollen allergy is a reaction which occurs soon after exposure to pollen of birch trees. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching, or tingling in or around the mouth and throat, digestive problems, such as diarrhea, stomach cramps, nausea or vomiting, tightening of the throat, shortness of breath or wheezing and runny nose.
The Birch Pollen Allergy – Drugs In Development, research report provides comprehensive overview on the therapeutics under development for Birch Pollen Allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Birch Pollen Allergy and features dormant and discontinued projects.
Key Target in the Birch Pollen Allergy Pipeline Drugs Market
The key target in the Birch Pollen Allergy pipeline drugs market is Pollen Allergen Bet v 1.
Key RoA in the Birch Pollen Allergy Pipeline Drugs Market
The key routes of administration in the Birch Pollen Allergy pipeline drugs market are intravenous, sublingual, and subcutaneous.
Birch Pollen Allergy Pipeline Drugs Market, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Birch Pollen Allergy Pipeline Drugs Market
The key molecule types in the Birch Pollen Allergy pipeline drugs market are Allergenics (Allergen), Monoclonal Antibody, Subunit Vaccine and Vaccine.
Birch Pollen Allergy Pipeline Drugs Market, by Molecule Type
To get more updates on the top molecule types, download a free sample report
Major Companies in the Birch Pollen Allergy Pipeline Drugs Market
The major companies in the Birch Pollen Allergy pipeline drugs market are Regeneron Pharmaceuticals Inc, Allergy Therapeutics Plc, Desentum Oy, HAL Allergy BV, Roxall Medizin GmbH, Worg Pharmaceuticals, and S-TARget therapeutics GmbH.
Birch Pollen Allergy Pipeline Drugs Market, by Companies
For more company insights, download a free sample report
Birch Pollen Allergy Pipeline Drugs Market Overview
Key target | Pollen Allergen Bet v 1 |
Key molecules | Allergenics (Allergen), Monoclonal Antibody, Subunit Vaccine and Vaccine |
Key routes | Intravenous, Sublingual, and Subcutaneous |
Key companies | Regeneron Pharmaceuticals Inc, Allergy Therapeutics Plc, Desentum Oy, HAL Allergy BV, Roxall Medizin GmbH, Worg Pharmaceuticals, and S-TARget therapeutics GmbH |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Birch Pollen Allergy
- The pipeline guide reviews pipeline therapeutics for Birch Pollen Allergy by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Birch Pollen Allergy therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Birch Pollen Allergy therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Birch Pollen Allergy
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Birch Pollen Allergy
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Birch Pollen Allergy pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Desentum Oy
HAL Allergy BV
Regeneron Pharmaceuticals Inc
Roxall Medizin GmbH
S-TARget therapeutics GmbH
Worg Pharmaceuticals Hangzhou Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What is the key target in the Birch Pollen Allergy pipeline drugs market?
The key target in the Birch Pollen Allergy pipeline drugs market is Pollen Allergen Bet v 1.
-
What are the key molecule types in the Birch Pollen Allergy pipeline drugs market?
In the Birch Pollen Allergy pipeline drugs market, the most significant molecule types are Allergenics (Allergen), Monoclonal Antibody, Subunit Vaccine and Vaccine.
-
What are the major routes of administration in the Birch Pollen Allergy pipeline drugs market?
The major routes of administration in the Birch Pollen Allergy pipeline drugs market are intravenous, sublingual, and subcutaneous.
-
What are the major companies in the Birch Pollen Allergy pipeline drugs market?
The key companies in the Birch Pollen Allergy pipeline drugs market are Regeneron Pharmaceuticals Inc, Allergy Therapeutics Plc, Desentum Oy, HAL Allergy BV, Roxall Medizin GmbH, Worg Pharmaceuticals, and S-TARget therapeutics GmbH.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.